Diagnostic Technology Companies
Diagnostic technology companies within the investment space have witnessed a lot of action in last five years. Bigger companies such as Cancer Genetics Inc. have aggressively looked for inorganic growth in acquisitions below deal size of $25 million. Top technologies that got acquired in the $25-million category were pathogen capture systems (PCS), specialized testing for tick-borne diseases, a field of injury genomic technology platform, Leuko64 platformoncology-focused molecular diagnostic services, rapid point of care diagnostic testing products (POCT) such as FOB (Fecal Occult Blood) tests, pregnancy tests and infectious disease tests and pharmacogenomics, genotyping, and bio repository services.
LIST (XL LINK) OF SEVEN DIAGNOSTIC COMPANIES THAT WERE ACQUIRED FOR UNDER $25 MILLION BETWEEN 2014-2018
By deal size, top seven diagnostic technology companies that were acquired for under $25 million in the last five years in the United States:
All of these companies were private limited companies having specialization in one specific diagnostic technology. For example, NanoMR specializes in immunomagnetic pathogen capture system (PCS) that is a novel system for rapid isolation of rare cells in the bloodstream. Being a private limited company, annual revenues/EBIDTA data is not available for all. Full details are available within the attached spreadsheet.